Angelika M. Starzer
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 7
- COVID-19 and healthcare impacts 5
- Lung Cancer Research Studies 4
-
- Immunotherapy and Immune Responses 3
-
- Brain Metastases and Treatment 8
-
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 and COVID-19 Research 3
-
- Radiopharmaceutical Chemistry and Applications 3
- Co-authors
- Anna S. BerghoffMatthias PreusserGeorg WidhalmGerwin HellerAriane SteindlKarin DieckmannThorsten FuerederJ.M. Berger
- Partner nations
- AustriaUnited StatesSwitzerland
In The Last Decade
Angelika M. Starzer
25 papers receiving 478 citations
Peers
Comparison fields: 5 of 68
- Oncology 300
- Immunology 117
- Pulmonary and Respiratory Medicine 140
- Infectious Diseases 75
- Cancer Research 51
Countries citing papers authored by Angelika M. Starzer
This map shows the geographic impact of Angelika M. Starzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelika M. Starzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelika M. Starzer more than expected).
Fields of papers citing papers by Angelika M. Starzer
This network shows the impact of papers produced by Angelika M. Starzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelika M. Starzer. The network helps show where Angelika M. Starzer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Angelika M. Starzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 12 | |
| 4 | 2024 | 14 | |
| 5 | 2024 | 11 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 14 | |
| 10 | 2022 | 19 | |
| 11 | 2021 | 22 | |
| 12 | 2021 | 3 | |
| 13 | 2021 | 28 | |
| 14 | 2020 | 12 | |
| 15 | 2020 | 8 | |
| 16 | 2020 | 1 | |
| 17 | 2020 | 24 | |
| 18 | 2020 | 28 | |
| 19 | 2019 | 122 | |
| 20 | 2018 | 1 |
About Angelika M. Starzer
Angelika M. Starzer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics, having authored 27 papers that have together received 482 indexed citations. Recurring topics across this work include Brain Metastases and Treatment (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), COVID-19 and healthcare impacts (5 papers), COVID-19 Clinical Research Studies (4 papers), Lung Cancer Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Oncology (300 citations), Immunology (117 citations) and Pulmonary and Respiratory Medicine (140 citations). Angelika M. Starzer has collaborated with scholars based in Austria, United States and Switzerland. Frequent co-authors include Anna S. Berghoff, Matthias Preusser, Georg Widhalm, Gerwin Heller, Ariane Steindl, Karin Dieckmann, Thorsten Fuereder, J.M. Berger, Wolfgang Lamm and Robert Straßl. Their work appears in journals such as Journal of Clinical Oncology, Blood and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.